Some patients at our practice are taking part in a research study to assess a new treatment for heart attacks and strokes.
ORION-4 is a research study which aims to find out if a new cholesterol lowering injection safely reduces the risk of heart attacks and strokes in people who have already had one of these conditions, or who have had an operation or procedure to unblock their arteries. 
The study is coordinated by the University of Oxford and co-sponsored by The University of Oxford and The Medicines Company in collaboration with researchers at the TIMI Study Group at Brigham and Women’s Hospital in Boston, USA.
About 15,000 people aged 55 years or older will take part in this study. Half will get inclisiran injections and half will get dummy (inactive placebo) injections. Which treatment a person gets is decided by chance and neither participants nor their doctors will know which treatment they are given (i.e. this is a 'double-blind' randomized trial). Participants are asked to stay in the study for about five years.
Patients who meet the eligibility criteria may be contacted by the study team to be invited onto this trial.
The study information leaflet is accessed by following the link - click here and clicking on the top item to download it.
You can also watch a video presented by Professor Louise Bowman and access more information by clicking here
If you have any more questions, please contact the Practice Manager at this surgery.